SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Abhimanyu Ghose, Ria Kundu, Anis Toumeh, Catherine Hornbeck, Iman Mohamed, A Review of Obesity, Insulin Resistance, and the Role of Exercise in Breast Cancer Patients, Nutrition and Cancer, 2015, 67, 2, 197

    CrossRef

  2. 2
    Machiko Minatoya, Goro Kutomi, Hiroaki Shima, Sumiyo Asakura, Seiko Otokozawa, Hirofumi Ohnishi, Hiroshi Akasaka, Tetsuji Miura, Mitsuru Mori, Koichi Hirata, Relation of Serum Adiponectin Levels and Obesity with Breast Cancer: A Japanese Case-Control Study, Asian Pacific Journal of Cancer Prevention, 2014, 15, 19, 8325

    CrossRef

  3. 3
    Catherine S. Wright, Rebecca F. Berends, David J. Flint, Patricia E.M. Martin, Cell motility in models of wounded human skin is improved by Gap27 despite raised glucose, insulin and IGFBP-5, Experimental Cell Research, 2013, 319, 4, 390

    CrossRef

  4. 4
    Carol J. Fabian, Bruce F. Kimler, Joseph E. Donnelly, Debra K. Sullivan, Jennifer R. Klemp, Brian K. Petroff, Teresa A. Phillips, Trina Metheny, Sonya Aversman, Hung-wen Yeh, Carola M. Zalles, Gordon B. Mills, Stephen D. Hursting, Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women, Breast Cancer Research and Treatment, 2013, 142, 1, 119

    CrossRef

  5. 5
    Mojtaba Malek, Rokhsareh Aghili, Zahra Emami, Mohammad E. Khamseh, Risk of Cancer in Diabetes: The Effect of Metformin, ISRN Endocrinology, 2013, 2013, 1

    CrossRef

  6. 6
    Amina Amadou, Pierre Hainaut, Isabelle Romieu, Role of Obesity in the Risk of Breast Cancer: Lessons from Anthropometry, Journal of Oncology, 2013, 2013, 1

    CrossRef

  7. 7
    Philippe Autier, Alice Koechlin, Mathieu Boniol, Patrick Mullie, Geremia Bolli, Julio Rosenstock, Peter Boyle, Serum insulin and C-peptide concentration and breast cancer: a meta-analysis, Cancer Causes & Control, 2013, 24, 5, 873

    CrossRef

  8. 8
    Maria E. Ramos-Nino, The Role of Chronic Inflammation in Obesity-Associated Cancers, ISRN Oncology, 2013, 2013, 1

    CrossRef

  9. 9
    Mohamed K. Mehasseb, Mahmood I. Shafi, Obesity, 2013,

    CrossRef

  10. 10
    Yingmei Wang, Shaofang Hua, Wenyan Tian, Lizhi Zhang, Jing Zhao, Huiying Zhang, Wei Zhang, Fengxia Xue, Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase/Akt dependent, Gynecologic Oncology, 2012, 125, 3, 734

    CrossRef

  11. 11
    David D. Shersher, Michael S. Vercillo, Cristina Fhied, Sanjib Basu, Omid Rouhi, Brett Mahon, John S. Coon, William H. Warren, L. Penfield Faber, Edward Hong, Philip Bonomi, Michael J. Liptay, Jeffrey A. Borgia, Biomarkers of the Insulin-Like Growth Factor Pathway Predict Progression and Outcome in Lung Cancer, The Annals of Thoracic Surgery, 2011, 92, 5, 1805

    CrossRef

  12. 12
    L.A. Healy, A.M. Ryan, P. Carroll, D. Ennis, V. Crowley, T. Boyle, M.J. Kennedy, E. Connolly, J.V. Reynolds, Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer, Clinical Oncology, 2010, 22, 4, 281

    CrossRef

  13. 13
    Ian F. Godsland, Insulin resistance and hyperinsulinaemia in the development and progression of cancer, Clinical Science, 2009, 118, 5, 315

    CrossRef

  14. 14
    A. Belfiore, M. Genua, R. Malaguarnera, PPAR-γAgonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer, PPAR Research, 2009, 2009, 1

    CrossRef

  15. 15
    Anne E. Cust, Tanja Stocks, Annekatrin Lukanova, Eva Lundin, Göran Hallmans, Rudolf Kaaks, Håkan Jonsson, Pär Stattin, The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study, Breast Cancer Research and Treatment, 2009, 113, 3, 567

    CrossRef

  16. 16
    Paola Pisani, Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies, Archives Of Physiology And Biochemistry, 2008, 114, 1, 63

    CrossRef

  17. 17
    C. Pichard, G. Plu-Bureau, M. Neves-e Castro, A. Gompel, Insulin resistance, obesity and breast cancer risk, Maturitas, 2008, 60, 1, 19

    CrossRef

  18. 18
    Andrew G. Renehan, Darren L. Roberts, Caroline Dive, Obesity and cancer: Pathophysiological and biological mechanisms, Archives Of Physiology And Biochemistry, 2008, 114, 1, 71

    CrossRef

  19. 19
    L. Vona-Davis, M. Howard-McNatt, D. P. Rose, Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer, Obesity Reviews, 2007, 8, 5
  20. 20
    Maria Luisa Garmendia, Ana Pereira, Maria Elena Alvarado, Eduardo Atalah, Relation between Insulin Resistance and Breast Cancer among Chilean Women, Annals of Epidemiology, 2007, 17, 6, 403

    CrossRef

  21. 21
    S. Starcke, G. Vollmer, Is there an estrogenic component in the metabolic syndrome?, Genes & Nutrition, 2006, 1, 3-4, 177

    CrossRef

  22. 22
    Dana E. Rollison, Craig J. Newschaffer, Yuzhen Tao, Michael Pollak, Kathy J. Helzlsouer, Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer, International Journal of Cancer, 2006, 118, 5
  23. 23
    Martijn Verheus, Petra H.M. Peeters, Sabina Rinaldi, Laure Dossus, Carine Biessy, Anja Olsen, Anne Tjønneland, Kim Overvad, Majbritt Jeppesen, Françoise Clavel-Chapelon, Bertrand Téhard, Gabriele Nagel, Jakob Linseisen, Heiner Boeing, Petra H. Lahmann, Athina Arvaniti, Theodora Psaltopoulou, Antonia Trichopoulou, Domenico Palli, Rosario Tumino, Salvatore Panico, Carlotta Sacerdote, Sabina Sieri, Carla H. van Gils, Bas H. Bueno-de-Mesquita, Carlos A. González, Eva Ardanaz, Nera Larranaga, Carmen Martinez Garcia, Carmen Navarro, J. Ramón Quirós, Tim Key, Naomi Allen, Sheila Bingham, Kay-Tee Khaw, Nadia Slimani, Elio Riboli, Rudolf Kaaks, Serum C-peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC), International Journal of Cancer, 2006, 119, 3
  24. 24
    Laila Adly, Deirdre Hill, Mark E. Sherman, Susan R. Sturgeon, Thomas Fears, Carolyn Mies, Regina G. Ziegler, Robert N. Hoover, Catherine Schairer, Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women, International Journal of Cancer, 2006, 119, 10
  25. 25
    Herbert Kuhl, Breast cancer risk in the WHI study: The problem of obesity, Maturitas, 2005, 51, 1, 83

    CrossRef

  26. 26
    A. G. Renehan, M. Zwahlen, M. Egger, S. M. Shalet, IGF-I; IGF-binding protein-3 and breast cancer risk, Breast Cancer Online, 2005, 8, 01

    CrossRef

  27. 27
    Carlo Campagnoli, Chiara Abbà, Simona Ambroggio, Clementina Peris, Pregnancy, progesterone and progestins in relation to breast cancer risk, The Journal of Steroid Biochemistry and Molecular Biology, 2005, 97, 5, 441

    CrossRef

  28. 28
    Carlo Campagnoli, Françoise Clavel-Chapelon, Rudolf Kaaks, Clementina Peris, Franco Berrino, Progestins and progesterone in hormone replacement therapy and the risk of breast cancer, The Journal of Steroid Biochemistry and Molecular Biology, 2005, 96, 2, 95

    CrossRef

  29. 29
    Laura Lewis Frank, Cancer Prevention and Management through Exercise and Weight Control, 2005,

    CrossRef

  30. 30
    D. P. Rose, D. Komninou, G. D. Stephenson, Obesity, adipocytokines, and insulin resistance in breast cancer, Obesity Reviews, 2004, 5, 3
  31. 31
    Eugenia E. Calle, Rudolf Kaaks, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nature Reviews Cancer, 2004, 4, 8, 579

    CrossRef

  32. 32
    J H Hanke, K R Webster, L V Ronco, Protein biomarkers and drug design for cancer treatments, European Journal of Cancer Prevention, 2004, 13, 4, 297

    CrossRef

  33. 33
    Maureen Sanderson, Xiao Ou Shu, Herbert Yu, Qi Dai, Alecia S. Malin, Yu-Tang Gao, Wei Zheng, Reports: Insulin-Like Growth Factor-I, Soy Protein Intake, and Breast Cancer Risk, Nutrition and Cancer, 2004, 50, 1, 8

    CrossRef